在2024年第三季度财报电话会议上，Prophase Labs, Inc. (Nasdaq: PRPH) 首席执行官Ted Karkus全面介绍了公司的战略计划，重点关注即将推出的DNA Complete和DNA Expand产品、PMI的积极扩张以及成本削减计划。公司还在为即将进行的融资做准备，以支持这些计划。 Karkus强调了公司多样化的产品组合和强劲的市场需求，特别突出了食道癌检测的巨大潜 ...

英为财情Investing.com - ProPhase Labs (NASDAQ: PRPH )星期三发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.350，总营收为$3.15M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$2.82M，每股收益为$-0.310.

Hello, and good morning, everyone. Welcome to today's presentation. My name is Noella Alexander-Young, the virtual event ...

ProPhase Labs Inc (PRPH) outlines aggressive product launches and cost-cutting measures while addressing significant accounts receivable issues.

ProPhase Labs (PRPH) announced the launch of DNA Complete, offering a direct-to-consumer DNA test that sequences virtually 100% of a ...

ProPhase Labs (PRPH) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the ...

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the closing of its ...

ProPhase Labs PRPH is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

On behalf of our team, we'd like to thank everyone for joining us today for the presentation of ProPhase Labs for the Third Quarter 2024 Results. ProPhase is trading on the NASDAQ under the ticker ...

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and ...

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase” or the "Company”), a next-generation biotech, genomics and diagnostics company, today announced the ...

ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures ...